P021 ADALIMUMAB TROUGH SERUM LEVELS AND CLINICAL RESPONSE IN A SINGLE-CENTER COHORT OF INFLAMMATORY BOWEL DISEASE PATIENTS: CAN TROUGH SERUM LEVELS SERVE AS A PREDICTOR FOR FUTURE LOSS OF RESPONSE? | Zendy

AI Assistant Blog Pricing

P021 ADALIMUMAB TROUGH SERUM LEVELS AND CLINICAL RESPONSE IN A SINGLE-CENTER COHORT OF INFLAMMATORY BOWEL DISEASE PATIENTS: CAN TROUGH SERUM LEVELS SERVE AS A PREDICTOR FOR FUTURE LOSS OF RESPONSE?

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.